 |
|
Efficacy of a New Cephalosporin for Acute Otitis Media
Andrew J. Hotaling, MD;
William J. Doyle, PhD;
Erdem I. Cantekin, PhD
Arch Otolaryngol Head Neck Surg. 1987;113(4):370-373.
Abstract
• The efficacy of a new third-generation cephalosporin, cefixime, in the treatment of acute otitis media resulting from infection with ampicillin-resistant, β-lactamase-producing nontypable Haemophilus influenzae, was evaluated using the chinchilla animal model. The results showed that cefixime, administered in moderately low doses (8 mg/kg of body weight, two times per day), readily penetrated the chinchilla middle ear and rapidly sterilized the effusion. The data also suggest that the effusions were resolved more quickly in the cefixime-treated group compared with a group of animals treated with ampicillin or an untreated control group. No adverse side effects were noted in the cefixime-treated animals. The results of this study warrant the testing of cefixime for acute otitis media in the clinical setting.
(Arch Otolaryngol Head Neck Surg 1987;113:370-373)
Author Affiliations
From the Department of Otolaryngology, University of Pittsburgh School of Medicine, and the Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh.
Footnotes
Accepted for publication Oct 6, 1986.
Reprint requests to Department of Pediatric Otolaryngology, Children's Hospital of Pittsburgh, 1 Children's Place, 3750 Fifth Ave at DeSoto Street, Pittsburgh, PA 15213 (Dr Doyle).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Third-Generation Cephalosporins in the Treatment of Acute Pneumococcal Otitis Media: An Animal Study
Rosenfeld et al.
Arch Otolaryngol Head Neck Surg 1992;118:49-52.
ABSTRACT
|
